Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

221.38 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cidara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 01, 2022

Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...

Via Benzinga

Cidara Therapeutics's Return On Capital Employed Insights ↗

March 10, 2022

According to Benzinga Pro data, during Q4, Cidara Therapeutics (NASDAQ:CDTX) posted sales of $7.22 million. Earnings were up 7.08%, but Cidara Therapeutics still reported an...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 02, 2022

Gainers Eargo (NASDAQ:EAR) shares rose 10....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza ↗

February 14, 2022

The FDA has signed off Cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC), CD388 for...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 03, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX)...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 20, 2021

Gainers Intra-Cellular Therapies (NASDAQ:ITCI) stock rose 18.79% to $46.52 during Monday's pre-market session. The market value of their outstanding shares is at $3.7...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

Cidara Therapeutics Stock Slides Despite Acing Rezafungin Trial In Fungal Infection ↗

December 14, 2021

Cidara Therapeutics Inc (NASDAQ: CDTX) and Mundipharma posted topline data from the ReSTORE Phase 3 trial of rezafungin for candidemia and invasive candidiasis...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 14, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals (NASDAQ:ARNA) stock moved upwards by 91.22% to $95.5 during Monday's pre-market session. The company's market cap stands at $5.8...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 16, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

26 Stocks Moving in Friday's Pre-Market Session ↗

October 22, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) rose 300% to $6.10 in pre-market trading. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition...

Via Benzinga

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

October 08, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...

Via Benzinga

18 Stocks Moving in Friday's Pre-Market Session ↗

October 08, 2021

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 07, 2021

Gainers Vaxart (NASDAQ:VXRT) shares incr...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021 ↗

September 22, 2021

Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE:

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

September 15, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

2 Biotech Stocks Wall Street Predicts Will Double ↗

August 29, 2021

Biotechnology is advancing rapidly, driven by robust investments in new developments and a demand for synthetic biology. The industry is expected to continue to generate significant growth over an...

Via Talk Markets

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 30, 2021

Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures ↗

July 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

Could Johnson & Johnson Be a Big Winner in the Flu Vaccine Market? ↗

April 14, 2021

Maybe, but there's a long way to go.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.